Bryce Pardo is a policy researcher at the RAND Corporation. His work focuses on drug policy with a particular interest in the areas of cannabis regulation, opioid control, and new psychoactive substance markets. He has over ten years of experience working with national, state, and local governments in crime and drug policy. Recently, he has provided Congressional testimony about his research on illicit supply of fentanyl to several subcommittees within the U.S. House of Representatives. Prior to joining RAND, he served five years as a legislative and policy analyst at the Inter-American Drug Abuse Control Commission (CICAD) within the Organization of American States (OAS) where he worked directly with policymakers and practitioners. He has independently consulted with multi-lateral institutions, including the Pan-American Health Organization (PAHO) and the United Nations Office on Drugs and Crime (UNODC). Pardo also served as lead analyst with BOTEC Analysis Corporation to support the Government of Jamaica in drafting medical cannabis regulations. His research and academic works have been published in the International Journal of Drug Policy, Addiction, Lancet Psychology, Criminology and Public Policy, and reports for the London School of Economics, UNODC, PAHO, and the National Academy of Sciences. Pardo holds a Ph.D. in public policy from the University of Maryland, College Park and an M.A. in Latin American studies and a B.A. in political science from the George Washington University.